After extensive discussion, AASLD, EASL & others have adopted a new naming system for fatty liver disease, intended to emphasize the underlying metabolic cause & reduce stigma by de-emphasizing alcohol & retiring "fatty". #TLM2023 #TLM23
www.hepmag.com/article/name...
www.hepmag.com/article/name...
What’s in a Name? NAFLD Is Now MASLD
Name change emphasizes the role of metabolic dysfunction in fatty liver disease.
www.hepmag.com
November 12, 2023 at 12:10 AM
After extensive discussion, AASLD, EASL & others have adopted a new naming system for fatty liver disease, intended to emphasize the underlying metabolic cause & reduce stigma by de-emphasizing alcohol & retiring "fatty". #TLM2023 #TLM23
www.hepmag.com/article/name...
www.hepmag.com/article/name...
#TLM23 is only a week away! Looking forward to meeting many #livertwitter peeps I have never interacted with in person at the @AASLDtweets liver meeting in Boston!
December 2, 2024 at 6:54 PM
#TLM23 is only a week away! Looking forward to meeting many #livertwitter peeps I have never interacted with in person at the @AASLDtweets liver meeting in Boston!
A great @AASLDtweets annual tradition is the @CLDFoundation abstract review. Thank you for continuing to be the only CME accredited educator solely focused on educating about liver disease. #TLM23
December 2, 2024 at 6:49 PM
A great @AASLDtweets annual tradition is the @CLDFoundation abstract review. Thank you for continuing to be the only CME accredited educator solely focused on educating about liver disease. #TLM23
Live from Boston! Prof Sanyal presents data from the NIMBLE cohort showing very few persons would be reclassified as having cryptogenic steatosis or cirrhosis based on new nomenclature @AASLDtweets #TLM23
December 2, 2024 at 6:49 PM
Live from Boston! Prof Sanyal presents data from the NIMBLE cohort showing very few persons would be reclassified as having cryptogenic steatosis or cirrhosis based on new nomenclature @AASLDtweets #TLM23
@HannesHagstrom presents data suggesting you should just swap existing ICD codes for #NAFLD to #MASLD and #NASH to #MASH and create a new category for #MetALD
People will widely adopt when they can bill appropriately so this is important to address ASAP. @AASLDtweets #TLM23
People will widely adopt when they can bill appropriately so this is important to address ASAP. @AASLDtweets #TLM23
December 2, 2024 at 6:49 PM
@US_FDA communication to stakeholders and sponsors is that they will not mandate use of new nomenclature and are ok with using MASLD/ NAFLD and MASH/NASH interchangeably. @AASLDtweets #TLM23
December 2, 2024 at 6:44 PM
@US_FDA communication to stakeholders and sponsors is that they will not mandate use of new nomenclature and are ok with using MASLD/ NAFLD and MASH/NASH interchangeably. @AASLDtweets #TLM23
@US_FDA statement is that they will not mandate sponsors to use the new SLD nomenclature and use terms interchangeably @AASLDtweets #TLM23
December 2, 2024 at 6:44 PM
@US_FDA statement is that they will not mandate sponsors to use the new SLD nomenclature and use terms interchangeably @AASLDtweets #TLM23
Animated debate on the merits of liver transplantation in persons with alcohol associated hepatitis. @JoseeLynch @juanpabloarab @drbobbybrown @TiffanyWuMD @mandrekp @AASLDtweets #TLM23
December 2, 2024 at 6:44 PM
Animated debate on the merits of liver transplantation in persons with alcohol associated hepatitis. @JoseeLynch @juanpabloarab @drbobbybrown @TiffanyWuMD @mandrekp @AASLDtweets #TLM23
A truer statement has never been uttered! Please support @AASLDFoundation and it’s mission to advocate, support and advance research in hepatology! @AASLDtweets #TLM23
December 2, 2024 at 6:44 PM
A truer statement has never been uttered! Please support @AASLDFoundation and it’s mission to advocate, support and advance research in hepatology! @AASLDtweets #TLM23
The curtain falls on @AASLDtweets #TLM23 See you in San Diego next year. #livertwitter
December 2, 2024 at 6:38 PM
The curtain falls on @AASLDtweets #TLM23 See you in San Diego next year. #livertwitter
Flying in from San Diego, CA, we are honored to have Dr. Paul Pockros join us at the #LiverUpdate as our keynote speaker for the State-of-the-Art Lecture on Hepatitis C: From Discovery to Elimination! If you missed @AASLD #TLM23, join us on December 1st to get caught up!
March 8, 2025 at 3:35 AM
Flying in from San Diego, CA, we are honored to have Dr. Paul Pockros join us at the #LiverUpdate as our keynote speaker for the State-of-the-Art Lecture on Hepatitis C: From Discovery to Elimination! If you missed @AASLD #TLM23, join us on December 1st to get caught up!
Ready to level up? Meet the Red Nucleus team at The Liver Meeting in Boston. Advancing knowledge to improve lives™. We're ready to work with you. Contact us at info@rednucleus.com or rednucleus.com/contact?utm_...
🔴🧠
#hepatology #gastroenterology
🔴🧠
#hepatology #gastroenterology
November 9, 2023 at 2:43 PM
Ready to level up? Meet the Red Nucleus team at The Liver Meeting in Boston. Advancing knowledge to improve lives™. We're ready to work with you. Contact us at info@rednucleus.com or rednucleus.com/contact?utm_...
🔴🧠
#hepatology #gastroenterology
🔴🧠
#hepatology #gastroenterology